* T2 Biosystems Inc TTOO.OQ TTOO.O is expected to show a
fall
in quarterly revenue when it reports results on May 6 for the
period ending March 31 2024
* The Lexington Massachusetts-based company is expected to
report
a 23.0% decrease in revenue to $1.6 million from $2.08 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for T2 Biosystems Inc is for
a
loss of $1.86 per share.
* The one available analyst rating on the shares is
"hold".
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "Hold".
* Wall Street's median 12-month price target for T2
Biosystems Inc
is $3.00, below its last closing price of $3.65.
This summary was machine generated May 3 at 22:13 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)